Trend Cross Swing · 12/50 · 100D Trend · MA20>MA50

US MA20 Cross MA50 Screener Very Weak

Save Strategy Open Strategy

Current Setup

1 setup Showing 1 of 20

GILD Gilead Sciences, Inc. NASDAQ / Health technology

Ready To Follow As of 24 Apr 2026

1 Trigger Level USD 130.40

2 Downside Limit USD 119.96

3 Upside Target USD 153.87

4 Timed Exit 45d

Trigger Level USD 130.40 Downside Limit USD 119.96 Upside Target USD 153.87 Timed Exit 45d

No completed trade log is available for this strategy yet.

Expand

No completed trades are available yet for the charts.

Expand

Expand

Run the strategy first to generate the validation snapshot.